Agfa sells CardioNow

Article

A provider of data management services for clinical trials has purchased CardioNow from Agfa Healthcare.

Agfa sells CardioNow
A provider of data management  services for clinical trials has purchased CardioNow from Agfa Healthcare. With this acquisition, BioClinica plans to add within 45 days the ability to track, share, blindly interpret, and archive medical images for multi-center clinical trials to its services portfolio. Neither the price of the acquisition nor other details regarding the acquisition were publicly released.  Executives at BioClinica expect to integrate CardioNow services  into their portfolio, extending the company’s ability to manage the process that begins after a medical image is acquired as part of a clinical trial. Imaging information will also be integrated with BioClinica Express electronic data capture to simplify and enhance the clinical trial process for life science companies, according to BioClinica.

Recent Videos
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
Related Content
© 2025 MJH Life Sciences

All rights reserved.